NCT01121120 - Acceleration of Platelet Recovery Following Autologous Peripheral Blood Stem Cell Transplant (PBSC) in Hodgkin, Non-Hodgkin Lymphoma or Multiple Myeloma Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions

Lymphoma, Non-HodgkinHodgkin DiseaseMultiple Myeloma

Interventions

DRUG

TXA127

300mcg/kg/day, administered subcutaneously for up to 28 days

DRUG

Placebo

300mcg/kg/day administered subcutaneously for up to 28 days

Trial Locations (10)

Montefiori Medical Center, The Bronx

University of Virginia Health System, Charlottesville

IU Simon Cancer Center, Indianapolis

Rush University Medical Center, Chicago

Huntsman Cancer Institute, Salt Lake City

City of Hope Hospital, Duarte

Emory University, Atlanta

Washington University, St Louis

University of Nebraska Medical Center, Omaha

Stony Brook, Long Island City